deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02514356

SMS as an Incentive To Adhere (SITA) - An Intervention Communicating Social Norms by SMS to Improve ARV Adherence (SITA)

A Small Randomized Controlled Trial Providing Weekly Information by SMS About Own and Group-level ARV Adherence to Patients in Two Clinics in Uganda

Sponsor: RAND

Updated 6 times since 2017 Last updated: Apr 12, 2017 Started: Aug 31, 2015 Primary completion: Mar 7, 2017 Completion: Mar 7, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02514356, this NA trial focuses on Human Immunodeficiency Virus and remains completed. Sponsored by RAND, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. May 2017 — Jun 2018 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

Show 1 earlier version
  1. Jan 2017 — May 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • RAND
  • The AIDS Support Organization
Data source: RAND

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations